Conspectus “Theranostics” is a portmanteau that links the fields of therapeutics and
diagnostics; it describes a personalized medical approach with the expectation to improve …

During the last decades, the utilization of imaging modalities such as single photon emission
computed tomography (SPECT), positron emission tomography (PET), and magnetic …

Theranostics with radioligands (radiotheranostics) has played a pivotal role in oncology.
Radiotheranostics explores the molecular targets expressed on tumor cells to target them for …

There is increasing demand worldwide to develop diagnostic and therapeutic (theranostic)
markers for prostate cancer. One target of interest is prostate-specific membrane antigen …

The precise delivery of cytotoxic radiation to cancer cells through the combination of a
specific targeting vector with a radionuclide for targeted radionuclide therapy (TRT) has …

The development of peptide-based, radiometal-labeled PET imaging agents has seen an
increase in attention due to the favorable properties the peptide backbone exhibits. These …

Rheumatoid arthritis (RA) is a systemic autoimmune disorder caused by inflammation of
cartilaginous diarthrodial joints that destroys joints and cartilage, resulting in synovitis and …

To harness radiometals in clinical settings, a chelator forming a stable complex with the
metal of interest and targets the desired pathological site is needed. Toward this goal, we …

Recent clinical success with metal-based radiopharmaceuticals has sparked an interest in
the potential of these drugs for personalized medicine. Although often overlooked, the …

The development of theranostic radiotracers relies on their binding to specific molecular
markers of a particular disease and the use of corresponding radiopharmaceutical pairs …